http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14139713

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 862
issn 1387-2877
1875-8908
issueIdentifier 3
pageRange 849-862
publicationName Journal of Alzheimer's disease : JAD
startingPage 849
bibliographicCitation Kuntz M, Candela P, Saint-Pol J, Lamartinière Y, Boucau MC, Sevin E, Fenart L, Gosselet F. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier. J Alzheimers Dis. 2015;48(3):849–62. doi: 10.3233/jad-150469. PMID: 26402114.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05c32b5fba6200ea181a4d6bf9c348c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_657117f19c29242f7bc4ebffddc96ed7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_801854f18abfbb7d7462b3352e0c3f8f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34c5c62a765c22917f737c11382e98df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_567a0e5be597d451a59a7731e52fcc31
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81d0d393867ff4d6bee607a30bf0e1f2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_822f8e51cd57da7404eada56068594d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9285-0579
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0481-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a66acbf3225dfa239b60f4787825eb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5153-0958
date 2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/26402114
https://doi.org/10.3233/jad-150469
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier
discusses http://id.nlm.nih.gov/mesh/M0027659
http://id.nlm.nih.gov/mesh/M0456332
http://id.nlm.nih.gov/mesh/M0021234
http://id.nlm.nih.gov/mesh/M0501360
http://id.nlm.nih.gov/mesh/M0001601
http://id.nlm.nih.gov/mesh/M0024786
http://id.nlm.nih.gov/mesh/M0250478
http://id.nlm.nih.gov/mesh/M0028008
http://id.nlm.nih.gov/mesh/M0367387
http://id.nlm.nih.gov/mesh/M0025302
http://id.nlm.nih.gov/mesh/M0004268
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001812Q000378
http://id.nlm.nih.gov/mesh/D016229Q000378
http://id.nlm.nih.gov/mesh/D018696Q000494
http://id.nlm.nih.gov/mesh/D002784Q000378
http://id.nlm.nih.gov/mesh/D013764Q000494
http://id.nlm.nih.gov/mesh/D001812Q000187
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002199Q000187
http://id.nlm.nih.gov/mesh/D013234
http://id.nlm.nih.gov/mesh/D019108Q000378
http://id.nlm.nih.gov/mesh/D002199Q000502
http://id.nlm.nih.gov/mesh/D016588Q000494
http://id.nlm.nih.gov/mesh/D064286Q000378
http://id.nlm.nih.gov/mesh/D020286
http://id.nlm.nih.gov/mesh/D001692Q000187
http://id.nlm.nih.gov/mesh/D019108Q000187
http://id.nlm.nih.gov/mesh/D001057Q000378
http://id.nlm.nih.gov/mesh/D005312
http://id.nlm.nih.gov/mesh/D000077610
http://id.nlm.nih.gov/mesh/D018435Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018920
http://id.nlm.nih.gov/mesh/D002417
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b41adbd094947475b63355088c8b2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d22ef8d03375d89409872210d728cfc0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_178dc25898bb18e8ab8a8d614583feb9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852

Total number of triples: 70.